PCR Journal Club

An active surveillance programme was initiated by the Israeli Ministry of Health to ascertain the possible causal relationship between the vaccine and myocarditis and evaluate incidence, clinical relevance, and related outcomes.

Through this registry-based analysis, the authors sought to assess short and long-term outcomes of revascularisation in a latecomer STEMI population presenting between 12 to 48 hours of symptom onset.

According to the updated international revascularization guidelines, fractional flow reserve (FFR) and instantaneous wave-free period ratio (iFR) are proposed to dichotomize decision-making for ischemia detection in guiding percutaneous coronary intervention (PCI) of intermediate coronary stenosis.

The current meta-analysis highlights that mechanical thrombectomy with retrievable stents or aspiration catheters reduced disability and all-cause mortality at 90 days in acute anterior circulation ischaemic stroke.

Structural valve deterioration remains the Achilles heel of both SAVR and TAVI. Since indications for TAVI have expanded to low-risk patients in 2019, this clinical scenario poses a significant conundrum for physicians and surgeons, as the number of patients undergoing aortic valve interventions continues to grow...

The objective of the IAMI1 trial was to determine whether early influenza vaccination reduces the risk of cardiovascular events in patients admitted with an acute-MI or high-risk stable coronary artery disease in an adequately powered randomized control trial setting.

The IMICA trial explored the effect of a single 1-hour infusion of Tocilizumab, initiated in patients as early as feasible in their hospital admission, post-cardiac arrest, and sought to investigate whether this would reduce the systemic inflammatory response.

Thanks to a case report, find out more about the technical steps by which imaging can be used to precisely position the stents and reduce contrast use.

The purpose of the present investigation was to revisit all stent expansion indexes to identify the best predictor of 2-year percutaneous coronary intervention (PCI) lesion-specific outcome measures (i.e. clinically-driven target lesion revascularization [TLR] or definite stent thrombosis) using the ADAPT-DES IVUS substudy cohort.

The aims of this study were to assess the use of antiplatelet drugs in medically treated spontaneous coronary artery dissection (SCAD) patients and to investigate the relationship between single (SAPT) and dual (DAPT) antiplatelet regimens and 1-year patient outcomes.